methylprednisolone hemisuccinate has been researched along with metoclopramide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Baethge, BA; Lidsky, MD | 1 |
Erlichman, C; Levitt, M; Osoba, D; Pater, JL; Willan, AR | 1 |
Cook, RJ | 1 |
Cook, RJ; Willan, AR | 1 |
Chan, IS; Li, HQ; Tang, ML; Tang, NS; Tian, GL | 1 |
1 trial(s) available for methylprednisolone hemisuccinate and metoclopramide
Article | Year |
---|---|
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
Topics: Antineoplastic Agents; Anxiety; Gastrointestinal Diseases; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Sleep Stages; Vomiting | 1986 |
5 other study(ies) available for methylprednisolone hemisuccinate and metoclopramide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Intractable hiccups associated with high-dose intravenous methylprednisolone therapy.
Topics: Adult; Hiccup; Humans; Infusions, Parenteral; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Metoclopramide; Middle Aged | 1986 |
Interim analyses in 2 x 2 crossover trials.
Topics: Antiemetics; Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Mathematics; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Research Design | 1995 |
Design considerations in crossover trials with a single interim analysis and serial patient entry.
Topics: Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Linear Models; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Randomized Controlled Trials as Topic; Time Factors | 1996 |
Confidence-interval construction for rate ratio in matched-pair studies with incomplete data.
Topics: Antiemetics; Clinical Trials as Topic; Confidence Intervals; Humans; Likelihood Functions; Matched-Pair Analysis; Methylprednisolone Hemisuccinate; Metoclopramide; Models, Statistical; Sample Size; Vomiting | 2014 |